<SEC-DOCUMENT>0000950103-25-016365.txt : 20251219
<SEC-HEADER>0000950103-25-016365.hdr.sgml : 20251219
<ACCEPTANCE-DATETIME>20251219121220
ACCESSION NUMBER:		0000950103-25-016365
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251219
DATE AS OF CHANGE:		20251219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROYAL BANK OF CANADA
		CENTRAL INDEX KEY:			0001000275
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135357855
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-275898
		FILM NUMBER:		251586377

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		ROYAL BANK PLAZA
		STREET 2:		200 BAY STREET
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2J5
		BUSINESS PHONE:		212-437-9267

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		ROYAL BANK PLAZA
		STREET 2:		200 BAY STREET
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2J5

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROYAL BANK OF CANADA \
		DATE OF NAME CHANGE:	19950908
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp238987_424b2-wfceln351nvda.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="width: 67%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">PRICING SUPPLEMENT
    dated December 17, 2025</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 9pt">(To the Product
    Supplement No. WF1 dated December 20, 2023 and the Prospectus Supplement and the Prospectus, each dated December 20, 2023)</FONT></P></TD>
    <TD STYLE="white-space: nowrap; width: 33%"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration Statement
    No. 333-275898</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed Pursuant
    to Rule 424(b)(2)</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font: 12pt Times New Roman, Times, Serif; text-align: right"><IMG SRC="image_001.jpg" ALT=""></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EDEFEE">
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 98%">
    <P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><B>Royal Bank of Canada</B></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #BB0826"><FONT STYLE="font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-size: 11pt"><B>Senior
    Global Medium-Term Notes, Series J</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D5D9D8">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>$2,564,000 Market Linked Securities&mdash;Leveraged
    Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"><B>Principal at Risk Securities Linked to the Common
    Stock of NVIDIA Corporation due February 22, 2027</B></P></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Linked
                                            to the common stock of NVIDIA Corporation (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Unlike
                                            ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal
                                            at maturity. Instead, the securities provide for a maturity payment amount that may be greater
                                            than, equal to or less than the face amount of the securities, depending on the performance
                                            of the Underlying Stock from the starting value to the ending value. The maturity payment
                                            amount will reflect the following terms:</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 20.6pt"></TD><TD STYLE="background-color: rgb(94,138,180); width: 14.4pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">If
                                            the value of the Underlying Stock increases, you will receive the face amount <I>plus</I>
                                            a positive return equal to 150% of the percentage increase in the value of the Underlying
                                            Stock from the starting value to the ending value, subject to a maximum return at maturity
                                            of 31.20% of the face amount. As a result of the maximum return, the maximum maturity payment
                                            amount will be $1,312 per security.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 20.6pt"></TD><TD STYLE="background-color: rgb(94,138,180); width: 14.4pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">If
                                            the value of the Underlying Stock remains flat or decreases but the decrease is not more
                                            than the buffer amount of 15%, you will receive the face amount.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 20.6pt"></TD><TD STYLE="background-color: rgb(94,138,180); width: 14.4pt"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">If
                                            the value of the Underlying Stock decreases by more than the buffer amount, you will receive
                                            less than the face amount and will have 1-to-1 downside exposure to the decrease in the value
                                            of the Underlying Stock in excess of the buffer amount.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">Investors
                                            may lose up to 85% of the face amount.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">All
                                            payments on the securities are subject to credit risk, and you will have no ability to pursue
                                            the issuer of the Underlying Stock for payment; if Royal Bank of Canada, as issuer, defaults
                                            on its obligations, you could lose some or all of your investment.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">No
                                            periodic interest payments or dividends</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; color: red"><TR STYLE="vertical-align: top">
<TD STYLE="background-color: rgb(94,138,180); width: 0"></TD><TD STYLE="background-color: rgb(94,138,180); width: 0.2in"><FONT STYLE="font-family: Wingdings; color: White">n</FONT></TD><TD STYLE="background-color: rgb(94,138,180); text-align: justify; padding-right: 3.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: White">No
                                            exchange listing; designed to be held to maturity</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The initial estimated value of the securities
determined by us as of the pricing date, which we refer to as the initial estimated value, is $973.14 per security and is less than the
original offering price of the securities. The market value of the securities at any time will reflect many factors, cannot be predicted
with accuracy and may be less than this amount. We describe the determination of the initial estimated value in more detail below.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The securities have complex features and investing
in the securities involves risks not associated with an investment in conventional debt securities. See &ldquo;Selected Risk Considerations&rdquo;
beginning on page PS-8 herein and &ldquo;Risk Factors&rdquo; beginning on page PS-5 of the accompanying product supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The securities are the unsecured obligations
of Royal Bank of Canada, and, accordingly, all payments on the securities are subject to the credit risk Royal Bank of Canada. If Royal
Bank of Canada, as issuer, defaults on its obligations, you could lose some or all of your investment.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>None of the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;), any state securities commission or any other regulatory body has approved or disapproved of the securities or
passed upon the adequacy or accuracy of this pricing supplement. Any representation to the contrary is a criminal offense. The securities
will not constitute deposits insured by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any
other Canadian or U.S. governmental agency or instrumentality. The securities are not bail-inable notes and are not subject to conversion
into our common shares under subsection 39.2(2.3) of the Canada Deposit Insurance Corporation Act.</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-right: 4pt; border-bottom: #E0E3E2 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Original Offering Price</B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Agent Discount<SUP>(1)(2)</SUP></B></FONT></TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center; width: 25%"><FONT STYLE="font-size: 10pt"><B>Proceeds to Royal Bank of Canada</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-right: 4pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: #E0E3E2 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Per Security</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="white-space: nowrap; border-right: white 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$23.25</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: top; border-right: #E0E3E2 1pt solid; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$976.75</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-right: 4pt; vertical-align: top; border-right: white 1pt solid; border-bottom: #E0E3E2 1pt solid; border-left: #E0E3E2 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: #E0E3E2 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$2,564,000</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: white 1pt solid; border-bottom: #E0E3E2 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$59,613</FONT></TD>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-right: #E0E3E2 1pt solid; border-bottom: #E0E3E2 1pt solid; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt">$2,504,387</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">Wells Fargo Securities, LLC is the agent for the distribution of the securities and is acting as principal.
See &ldquo;Terms of the Securities&mdash;Agent&rdquo; and &ldquo;Estimated Value of the Securities&rdquo; in this pricing supplement for
further information.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.25pt"><SUP>(2)</SUP></TD><TD STYLE="text-align: justify">In addition to the forgoing, in respect of certain securities sold in this offering, our affiliate, RBC
Capital Markets, LLC (&ldquo;<U>RBCCM&rdquo;</U>), may pay a fee of up to $1.00 per security to selected securities dealers in consideration
for marketing and other services in connection with the distribution of the securities to other securities dealers.</TD></TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Wells Fargo Securities </B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; width: 100%; font: 12pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Terms of the Securities</B></FONT></TD></TR>
  </TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 4pt; width: 21%; border-bottom: white 1pt solid; font: 12pt Times New Roman, Times, Serif; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 79%; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-size: 10pt">Royal Bank of Canada</FONT></TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 4pt; background-color: rgb(217,217,214); vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 4pt"><FONT STYLE="font-size: 10pt">The common stock of NVIDIA Corporation (the &ldquo;<U>Underlying Stock</U>&rdquo;)</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; background-color: rgb(217,217,214); vertical-align: top; width: 21%; border-right: Black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding: 4pt; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Bloomberg Ticker Symbol</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 26%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Starting Value<SUP>(a)</SUP></B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 26%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Threshold Value<SUP>(b)</SUP></B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="padding: 4pt; border-right: Black 1pt solid; background-color: rgb(217,217,214); vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt"><B>Market Measure:</B></FONT></TD>
    <TD STYLE="padding: 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">NVDA UW</FONT></TD>
    <TD STYLE="padding: 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$170.94</FONT></TD>
    <TD STYLE="padding: 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$145.299</FONT></TD>
    </TR>
  <TR>
    <TD STYLE="padding: 4pt; background-color: rgb(217,217,214); vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 4pt"><FONT STYLE="font-size: 10pt"><SUP>(a)</SUP> The closing value of the Underlying Stock on the pricing date</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; background-color: rgb(217,217,214); vertical-align: top; text-align: center">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 4pt"><FONT STYLE="font-size: 10pt"><SUP>(b)</SUP> 85% of the starting value</FONT></TD></TR>
  </TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 4pt; width: 21%; border-top: white 1pt solid; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Pricing Date:</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 79%; text-align: justify"><FONT STYLE="font-size: 10pt">December 17, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Issue Date:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">December 22, 2025</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Calculation Day*:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">February 17, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Stated Maturity Date*:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">February 22, 2027</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Face Amount:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 per security. References in this pricing supplement to a &ldquo;<U>security</U>&rdquo; are to a security with a face amount of $1,000.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Maturity Payment <BR>
Amount:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">On the stated maturity date, you will
    be entitled to receive a cash payment per security in U.S. dollars equal to the maturity payment amount. The &ldquo;<U>maturity payment
    amount</U>&rdquo; per security will equal:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt">&bull;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.3in">if the ending value is greater than the starting value: $1,000
    <I>plus </I>the lesser of:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt; text-indent: -0.5in">(i)&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.6in">$1,000 &times; stock return &times; upside participation
    rate; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.25pt; text-indent: -0.5in">(ii)&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.6in">the maximum return;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.6in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt">&bull;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.3in">if the ending value is less than or equal to the starting
    value, but greater than or equal to the threshold value: $1,000; or</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt">&bull;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.45pt; text-indent: -12.2pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: -11pt 0pt 0pt 0.3in">if the ending value is less than the threshold value:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.7pt; text-align: center">$1,000 <FONT STYLE="font-family: Georgia, Times, Serif">+
    </FONT>[$1,000 &times; (stock return + buffer amount)]</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.7pt; text-align: center">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><B>If the ending value is less than
    the threshold value, you will have 1-to-1 downside exposure to the decrease in the value of the Underlying Stock in excess of the buffer
    amount and will lose up to 85% of the face amount of your securities at maturity.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify"></P></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-top: white 1pt solid; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Maximum Return:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">The &ldquo;<U>maximum return</U>&rdquo; is 31.20% of the face amount per security ($312 per security). As a result of the maximum return, the maximum maturity payment amount will be $1,312 per security.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Buffer Amount:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">15%</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Upside Participation <BR>
Rate:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">150%</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Stock Return:</B></FONT></TD>
    <TD STYLE="padding: 4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The &ldquo;<U>stock return</U>&rdquo;
    is the percentage change from the starting value to the ending value, calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.1in; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.05pt 0pt 8.65pt; text-align: center"><U>ending value &ndash; starting
value<BR>
</U>starting value&nbsp;</P></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Closing Value:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: top; text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;<U>Closing value</U>&rdquo; has the meaning assigned to &ldquo;stock closing price&rdquo; set forth under &ldquo;General Terms of the Securities&mdash;Certain Terms for Securities Linked to an Underlying Stock&mdash;Certain Definitions&rdquo; in the accompanying product supplement. The closing value of the Underlying Stock is subject to adjustment through the adjustment factor as described in the accompanying product supplement.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Ending Value:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">The &ldquo;<U>ending value</U>&rdquo; will be the closing value of the Underlying Stock on the calculation day.</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Calculation Agent:</B></FONT></TD>
    <TD STYLE="padding: 4pt; vertical-align: bottom"><FONT STYLE="font-size: 10pt">RBC Capital Markets, LLC (&ldquo;<U>RBCCM</U>&rdquo;)</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-top: white 1pt solid; border-bottom: white 1pt solid; background-color: #D9D9D6"><FONT STYLE="font-size: 10pt"><B>Material Tax <BR>
Consequences:</B></FONT></TD>
    <TD STYLE="padding: 4pt"><FONT STYLE="font-size: 10pt">For a discussion of the material U.S. federal income and certain estate tax consequences of the ownership and disposition of the securities, see the discussions in &ldquo;United States Federal Income Tax Considerations&rdquo; below and in the section entitled &ldquo;United States Federal Tax Considerations&rdquo; in the product supplement. For a discussion of the material Canadian federal income tax consequences relating to the securities, please see the section of the product supplement, &ldquo;Canadian Federal Income Tax Consequences.&rdquo;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-top: white 1pt solid; padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6; width: 21%"><FONT STYLE="font-size: 10pt"><B>Agent:</B></FONT></TD>
    <TD STYLE="padding: 4pt; width: 79%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Wells Fargo Securities, LLC (&ldquo;<U>WFS</U>&rdquo;).
    The agent will receive the agent discount set forth on the cover page of this pricing supplement. The agent may resell the securities
    to other securities dealers at the original offering price of the securities less a concession not in excess of $17.50 per security. Such
    securities dealers may include Wells Fargo Advisors (&ldquo;<U>WFA</U>&rdquo;) (the trade name of the retail brokerage business of WFS&rsquo;s
    affiliates, Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC). In addition to the concession allowed
    to WFA, WFS may pay $0.75 per security of the agent&rsquo;s discount to WFA as a distribution expense fee for each security sold by WFA.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.25pt; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">In addition to the forgoing, in respect
    of certain securities sold in this offering, our affiliate, RBCCM, may pay a fee of up to $1.00 per security to selected securities dealers
    in consideration for marketing and other services in connection with the distribution of the securities to other securities dealers. We
    or one of our affiliates will also pay an expected fee to a broker-dealer that is unaffiliated with us for providing certain electronic
    platform services with respect to this offering.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.25pt; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">WFS and/or RBCCM, and/or one or more
    of their respective affiliates, expects to realize hedging profits projected by their proprietary pricing models to the extent they assume
    the risks inherent in hedging our obligations under the securities. If WFS or any other dealer participating in the distribution of the
    securities or any of their affiliates conducts hedging activities for us in connection with the securities, that dealer or its affiliates
    will expect to realize a profit projected by its proprietary pricing models from those hedging activities. Any such projected profit will
    be in addition to any discount, concession or fee received in connection with the sale of the securities to you.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.25pt; text-align: justify"></P></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6; text-indent: 0.7pt"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">$1,000 and any integral multiple of $1,000</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 4pt; border-bottom: white 1pt solid; background-color: #D9D9D6; text-indent: 0.7pt"><FONT STYLE="font-size: 10pt"><B>CUSIP:</B></FONT></TD>
    <TD STYLE="padding: 4pt; text-align: justify"><FONT STYLE="font-size: 10pt">78017PQ87</FONT></TD></TR>
    </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 6.1pt">*</TD><TD STYLE="text-align: justify">The calculation day is subject to postponement due to non-trading days and the occurrence of a market
disruption event. In addition, the stated maturity date will be postponed if the calculation day is postponed and will be adjusted for
non-business days. For more information regarding adjustments to the calculation day and the stated maturity date, see &ldquo;General
Terms of the Securities&mdash;Consequences of a Market Disruption Event; Postponement of a Calculation Day&mdash;Securities Linked to
a Single Market Measure&rdquo; and &ldquo;&mdash;Payment Dates&rdquo; in the accompanying product supplement. In addition, for information
regarding the circumstances that may result in a market disruption event, see &ldquo;General Terms of the Securities&mdash;Certain Terms
for Securities Linked to an Underlying Stock&mdash;Market Disruption Events&rdquo; in the accompanying product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; font-size: 12pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Additional Information about the Issuer and the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should read this pricing supplement together
with the prospectus dated December 20, 2023, as supplemented by the prospectus supplement dated December 20, 2023, relating to our Senior
Global Medium-Term Notes, Series J, of which the securities are a part, and the product supplement no. WF1 dated December 20, 2023. <B>This
pricing supplement, together with these documents, contains the terms of the securities and supersedes all other prior or contemporaneous
oral statements as well as any other written materials, including preliminary or indicative pricing terms, correspondence, trade ideas,
structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not authorized anyone to provide any information
or to make any representations other than those contained or incorporated by reference in this pricing supplement and the documents listed
below. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give
you. These documents are an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where
it is lawful to do so. The information contained in each such document is current only as of its date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the information in this pricing supplement
differs from the information contained in the documents listed below, you should rely on the information in this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should carefully consider, among other things,
the matters set forth in &ldquo;Selected Risk Considerations&rdquo; in this pricing supplement and &ldquo;Risk Factors&rdquo; in the documents
listed below, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment,
legal, tax, accounting and other advisers before you invest in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>You may access these documents on the SEC website
at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000119312523299520/d645671d424b3.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://www.sec.gov/Archives/edgar/data/1000275/000119312523299520/d645671d424b3.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prospectus Supplement dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000119312523299523/d638227d424b3.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://www.sec.gov/Archives/edgar/data/1000275/000119312523299523/d638227d424b3.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Georgia, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Supplement No. WF1 dated December 20, 2023:<BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1000275/000114036123058587/ef20016916_424b5.htm" STYLE="color: Blue; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://www.sec.gov/Archives/edgar/data/1000275/000114036123058587/ef20016916_424b5.htm</FONT></A></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Georgia, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Central Index Key, or CIK, on the SEC website
is 1000275. As used in this pricing supplement, &ldquo;Royal Bank of Canada,&rdquo; the &ldquo;Bank,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo;
and &ldquo;us&rdquo; mean only Royal Bank of Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; font-size: 12pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">

</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Estimated Value of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities
is based on the value of our obligation to make the payments on the securities, together with the mid-market value of the derivative embedded
in the terms of the securities. Our estimate is based on a variety of assumptions, including our internal funding rate (which represents
a discount from our credit spreads), expectations as to dividends, interest rates and volatility, and the expected term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are our debt securities. As is
the case for all of our debt securities, including our structured notes, the economic terms of the securities reflect our actual or perceived
creditworthiness. In addition, because structured notes result in increased operational, funding and liability management costs to us,
we typically borrow the funds under structured notes at a rate that is lower than the rate that we might pay for a conventional fixed
or floating rate debt security of comparable maturity. The lower internal funding rate, the agent discount and the hedging-related costs
relating to the securities reduce the economic terms of the securities to you and result in the initial estimated value for the securities
being less than their original issue price. Unlike the initial estimated value, any value of the securities determined for purposes of
a secondary market transaction may be based on a secondary market rate, which may result in a lower value for the securities than if our
initial internal funding rate were used.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to satisfy our payment obligations under the securities, we
may choose to enter into certain hedging arrangements (which may include call options, put options or other derivatives) with the agent,
RBCCM and/or one of their respective affiliates. The terms of these hedging arrangements may take into account a number of factors, including
our creditworthiness, interest rate movements, volatility and the tenor of the securities. The economic terms of the securities and the
initial estimated value depend in part on the terms of these hedging arrangements. Our cost of hedging will include the projected profit
that we or our counterparty(ies) expect to realize in consideration for assuming the risks inherent in hedging our obligations under the
securities. Because hedging our obligations entails risks and may be influenced by market forces beyond our or our counterparty(ies)&rsquo;
control, such hedging may result in a profit that is more or less than expected, or could result in a loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">See &ldquo;Selected Risk Considerations&mdash;Risks Relating To The
Estimated Value Of The Securities And Any Secondary Market&mdash;The Initial Estimated Value Of The Securities Is Less Than The Original
Offering Price&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any price that the agent or RBCCM makes available
from time to time after the original issue date at which it would be willing to purchase the securities will generally reflect the agent&rsquo;s
or RBCCM&rsquo;s estimate of their value, as applicable, less a customary bid-ask spread for similar trades and the cost of unwinding
any related hedge transactions. That estimated value will be based upon a variety of factors, including then prevailing market conditions
and our creditworthiness. However, for a period of three months after the original issue date, the price at which the agent or RBCCM may
purchase the securities is expected to be higher than the price that would be determined based on the agent&rsquo;s or RBCCM&rsquo;s valuation,
respectively, at that time less the bid-ask spread and hedging unwind costs referenced above. This is because, at the beginning of this
period, that price will not include certain costs that were included in the original offering price, particularly a portion of the agent
discount and commission (not including the selling concession) and the expected profits that we or our hedging counterparty(ies) expect
to receive from our hedging transactions. As the period continues, these costs are expected to be gradually included in the price that
the agent or RBCCM would be willing to pay, and the difference between that price and the price that would be determined based on the
agent&rsquo;s or RBCCM&rsquo;s valuation of the securities, as applicable, less a bid-ask spread and hedging unwind costs will decrease
over time until the end of this period. After this period, if the agent or RBCCM continues to make a market in the securities, the prices
that it would pay for them are expected to reflect the agent&rsquo;s or RBCCM&rsquo;s estimated value, respectively, less the bid-ask
spread and hedging unwind costs referenced above. In addition, the value of the securities shown on your account statement will generally
reflect the price that the agent or RBCCM, as applicable, would be willing to pay to purchase the securities at that time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; font-size: 12pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">


</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Investor Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities are not appropriate for all
investors. The securities may be an appropriate investment for investors who:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">seek 150% leveraged exposure to the upside performance of the Underlying Stock if the ending value is
greater than the starting value, subject to the maximum return at maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">desire to limit downside exposure to the Underlying Stock through the buffer amount;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are willing to accept the risk that, if the ending value is less than the threshold value, they will have
1-to-1 downside exposure to the decrease in the value of the Underlying Stock in excess of the buffer amount and will lose up to 85% of
the face amount of their securities at maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are willing to forgo interest payments on the securities and dividends on the Underlying Stock; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are willing to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The securities may not be an appropriate investment
for investors who:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">seek a liquid investment or are unable or unwilling to hold the securities to maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">seek uncapped exposure to the upside performance of the Underlying Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">require full payment of the face amount of the securities at stated maturity;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are unwilling to purchase securities with an estimated value as of the pricing date that is lower than
the original offering price and that may be as low as the lower estimated value set forth on the cover page;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are unwilling to accept the risk that the ending value may be less than the threshold value;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">seek current income over the term of the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are unwilling to accept the risk of exposure to the Underlying Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">seek exposure to the Underlying Stock but are unwilling to accept the risk/return trade-offs inherent
in the maturity payment amount for the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">are unwilling to accept the credit risk of Royal Bank of Canada to obtain exposure to the Underlying Stock;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 12.2pt; font: 10pt Wingdings">&#167;</TD><TD STYLE="text-align: justify">prefer the lower risk of fixed income investments with comparable maturities issued by companies with
comparable credit ratings.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The considerations identified above are not
exhaustive. Whether or not the securities are an appropriate investment for you will depend on your individual circumstances, and you
should reach an investment decision only after you and your investment, legal, tax, accounting and other advisors have carefully considered
the appropriateness of an investment in the securities in light of your particular circumstances. You should also review carefully the
&ldquo;Selected Risk Considerations&rdquo; herein and the &ldquo;Risk Factors&rdquo; in the accompanying product supplement for risks
related to an investment in the securities. For more information about the Underlying Stock, see the section titled &ldquo;Information
about the Underlying Stock&rdquo; below.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Determining Payment at Stated Maturity</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date, you will receive
a cash payment per security (the maturity payment amount) calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0pt 0"><IMG SRC="image_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Selected Risk Considerations</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An investment in the securities involves significant
risks. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the securities. Some of
the risks that apply to an investment in the securities are summarized below, but we urge you to read also the &ldquo;Risk Factors&rdquo;
sections of the accompanying prospectus, prospectus supplement and product supplement. You should not purchase the securities unless you
understand and can bear the risks of investing in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Relating To The Terms And Structure
Of The Securities</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>If The Ending Value Is Less Than The Threshold
Value, You Will Lose Up To 85% Of The Face Amount Of Your Securities At Stated Maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not repay you a fixed amount on the securities
on the stated maturity date. The maturity payment amount will depend on the direction of and percentage change in the ending value relative
to the starting value and the other terms of the securities. Because the value of the Underlying Stock will be subject to market fluctuations,
the maturity payment amount may be more or less, and possibly significantly less, than the face amount of your securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the ending value is less than the threshold
value, the maturity payment amount will be less than the face amount and you will have 1-to-1 downside exposure to the decrease in the
value of the Underlying Stock in excess of the buffer amount, resulting in a loss of 1% of the face amount for every 1% decline in the
Underlying Stock in excess of the buffer amount. The threshold value is 85% of the starting value. As a result, if the ending value is
less than the threshold value, you will lose up to 85% of the face amount of your securities at maturity. This will be the case even if
the value of the Underlying Stock is greater than or equal to the starting value or the threshold value at certain times during the term
of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even if the ending value is greater than the starting
value, the maturity payment amount may only be slightly greater than the face amount, and your yield on the securities may be less than
the yield you would earn if you bought a traditional interest-bearing debt security of Royal Bank of Canada or another issuer with a similar
credit rating with the same stated maturity date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Your Return Will Be Limited To The Maximum
Return And May Be Lower Than The Return On A Direct Investment In The Underlying Stock.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opportunity to participate in the possible
increases in the value of the Underlying Stock through an investment in the securities will be limited because any positive return on
the securities will not exceed the maximum return, regardless of any increase in the value of the Underlying Stock, which may be significant.
Therefore, your return on the securities may be lower than the return on a direct investment in the Underlying Stock. Furthermore, the
effect of the upside participation rate will be progressively reduced for all ending values exceeding the ending value at which the maximum
return is reached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Securities Do Not Pay Interest, And Your Return On The Securities
May Be Lower Than The Return On A Conventional Debt Security Of Comparable Maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There will be no periodic interest payments on
the securities as there would be on a conventional fixed-rate or floating-rate debt security having the same maturity. The return that
you will receive on the securities, which could be negative, may be less than the return you could earn on other investments. Even if
your return is positive, your return may be less than the return you would earn if you purchased one of our conventional senior interest-bearing
debt securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Payments On The Securities Are Subject To Our Credit Risk, And Market
Perceptions About Our Creditworthiness May Adversely Affect The Market Value Of The Securities.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are our senior unsecured debt securities,
and your receipt of any amounts due on the securities is dependent upon our ability to pay our obligations as they come due. If we were
to default on our payment obligations, you may not receive any amounts owed to you under the securities and you could lose your entire
investment. In addition, any negative changes in market perceptions about our creditworthiness may adversely affect the market value of
the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The U.S. Federal Income Tax Consequences Of
An Investment In The Securities Are Uncertain. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no direct legal authority regarding the
proper U.S. federal income tax treatment of the securities, and significant aspects of the tax treatment of the securities are uncertain.
You should review carefully the section entitled &ldquo;United States Federal Income Tax Considerations&rdquo; herein, in combination
with the section entitled &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, and consult your
tax adviser regarding the U.S. federal income tax consequences of an investment in the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal"><B><U>Risks Relating
To The Estimated Value Of The Securities And Any Secondary Market</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>There May Not Be An Active Trading Market For
The Securities And Sales In The Secondary Market May Result In Significant Losses.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There may be little or no secondary market for
the securities. The securities will not be listed on any securities exchange. Either (a) the agent and/or its affiliates or (b) RBCCM
and our other affiliates may make a market for the securities; however, they are not required to do so and, if they choose to do so, may
stop any market-making activities at any time. Because other dealers are not likely to make a secondary market for the securities, the
price at which you may be able to trade your securities is likely to depend on the price, if any, at</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">which the agent, RBCCM or any of their respective
affiliates, as applicable, is willing to buy the securities. At this time, we do not expect both the agent (and/or its affiliates) and
RBCCM (and our other affiliates) to attempt to make a market for the securities at the same time. The agent&rsquo;s and RBCCM&rsquo;s
valuations of the securities may differ, and consequently the price at which you may be able to sell the securities, if at all, may differ
(and may be lower) depending on whether the agent or RBCCM is purchasing securities at that time. Even if a secondary market for the securities
develops, it may not provide enough liquidity to allow you to easily trade or sell the securities. We expect that transaction costs in
any secondary market would be high. As a result, the difference between bid and ask prices for your securities in any secondary market
could be substantial. If you sell your securities before maturity, you may have to do so at a substantial discount from the price that
you paid for them, and as a result, you may suffer significant losses. The securities are not designed to be short-term trading instruments.
Accordingly, you should be able and willing to hold your securities to maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Initial Estimated Value Of The Securities
Is Less Than The Original Offering Price.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities
is less than the original offering price of the securities and does not represent a minimum price at which we, RBCCM or any of our other
affiliates would be willing to purchase the securities in any secondary market (if any exists) at any time. If you attempt to sell the
securities prior to maturity, their market value may be lower than the price you paid for them and the initial estimated value. This is
due to, among other things, changes in the value of the Underlying Stock, the internal funding rate we pay to issue securities of this
kind (which is lower than the rate at which we borrow funds by issuing conventional fixed rate debt) and the inclusion in the original
offering price of the agent discount, our or our hedge counterparty(ies)&rsquo; estimated profit and the estimated costs related to our
hedging of the securities. These factors, together with various credit, market and economic factors over the term of the securities, are
expected to reduce the price at which you may be able to sell the securities in any secondary market and will affect the value of the
securities in complex and unpredictable ways.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Assuming no change in market conditions or any
other relevant factors, the price, if any, at which you may be able to sell your securities prior to maturity may be less than your original
purchase price, as any such sale price would not be expected to include the agent discount, our or our hedge counterparty(ies)&rsquo;
estimated profit or the hedging costs relating to the securities. In addition, any price at which you may sell the securities is likely
to reflect customary bid-ask spreads for similar trades. In addition to bid-ask spreads, the value of the securities determined for any
secondary market price is expected to be based on a secondary market rate rather than the internal funding rate used to price the securities
and determine the initial estimated value. As a result, the secondary market price will be less than if the internal funding rate was
used. Moreover, if the agent is making a market for the securities, any secondary market price will be based on the agent&rsquo;s valuation
of the securities, which may differ from (and may be lower than) the valuation that we would determine for the securities at that time
based on the methodology by which we determined the initial estimated value range set forth on the cover page of this pricing supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For a limited period of time after the original
issue date, the agent or RBCCM may purchase the securities at a price that is greater than the price that would otherwise be determined
at that time as described in the preceding paragraph. However, over the course of that period, assuming no changes in any other relevant
factors, the price you may receive if you sell your securities is expected to decline.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Initial Estimated Value Of The Securities
Is Only An Estimate, Calculated As Of The Time The Terms Of The Securities Are Set.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial estimated value of the securities
is based on the value of our obligation to make the payments on the securities, together with the mid-market value of the derivative embedded
in the terms of the securities. Our estimate is based on a variety of assumptions, including our internal funding rate (which represents
a discount from our credit spreads), expectations as to dividends on the Underlying Stock, interest rates and volatility, and the expected
term of the securities. These assumptions are based on certain forecasts about future events, which may prove to be incorrect. Other entities,
including the agent in connection with determining any secondary market price for the securities, may value the securities or similar
securities at a price that is significantly different than we do.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the securities at any time after
the pricing date will vary based on many factors, including changes in market conditions, and cannot be predicted with accuracy. As a
result, the actual value you would receive if you sold the securities in any secondary market, if any, should be expected to differ materially
from the initial estimated value of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The Value Of The Securities Prior To Stated
Maturity Will Be Affected By Numerous Factors, Some Of Which Are Related In Complex Ways.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The value of the securities prior to stated maturity
will be affected by the then-current value of the Underlying Stock, interest rates at that time and a number of other factors, some of
which are interrelated in complex ways. The effect of any one factor may be offset or magnified by the effect of another factor. The following
factors, which we refer to as the &ldquo;derivative component factors,&rdquo; and which are described in more detail in the accompanying
product supplement, are expected to affect the value of the securities: performance of the Underlying Stock; interest rates; volatility
of the Underlying Stock; time remaining to maturity; and dividend yields on the Underlying Stock. When we refer to the &ldquo;value&rdquo;
of your security, we mean the value you could receive for your security if you are able to sell it in the open market before the stated
maturity date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the derivative component factors,
the value of the securities will be affected by actual or anticipated changes in our creditworthiness. You should understand that the
impact of one of the factors specified above, such as a change in interest rates, may offset some or all of any change in the value of
the securities attributable to another factor, such as a change in the value of the Underlying Stock. Because numerous factors are expected
to affect the value of the securities, changes in the value of the Underlying Stock may not result in a comparable change in the value
of the securities. We anticipate that the value of the securities will always be at a discount to the face amount <I>plus</I> the maximum
return.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Risks Relating To Conflicts Of Interest</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Our Economic Interests And Those Of Any Dealer
Participating In The Offering Are Potentially Adverse To Your Interests.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should be aware of the following ways in which
our economic interests and those of any dealer participating in the distribution of the securities, which we refer to as a &ldquo;<U>participating
dealer</U>,&rdquo; are potentially adverse to your interests as an investor in the securities. In engaging in certain of the activities
described below and as discussed in more detail in the accompanying product supplement, our affiliates or any participating dealer or
its affiliates may take actions that may adversely affect the value of and your return on the securities, and in so doing they will have
no obligation to consider your interests as an investor in the securities. Our affiliates or any participating dealer or its affiliates
may realize a profit from these activities even if investors do not receive a favorable investment return on the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>The calculation agent is our affiliate and may be required to make discretionary judgments that
affect the return you receive on the securities.</I></B> RBCCM, which is our affiliate, will be the calculation agent for the securities.
As calculation agent, RBCCM will determine any values of the Underlying Stock and make any other determinations necessary to calculate
any payments on the securities. In making these determinations, RBCCM may be required to make discretionary judgments that may adversely
affect any payments on the securities. See the sections entitled &#8220;General Terms of the Securities&#8212;Certain Terms for Securities
Linked to an Underlying Stock&#8212;Market Disruption Events&#8221; and &#8220;&#8212;Adjustment Events&#8221; in the accompanying product
supplement. In making these discretionary judgments, the fact that RBCCM is our affiliate may cause it to have economic interests that
are adverse to your interests as an investor in the securities, and RBCCM&#8217;s determinations as calculation agent may adversely affect
your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>The estimated value of the securities was calculated by us and is therefore not an independent third-party
valuation.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>Research reports by our affiliates or any participating dealer or its affiliates may be inconsistent
with an investment in the securities and may adversely affect the value of the Underlying Stock.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>Business activities of our affiliates or any participating dealer or its affiliates with the Underlying
Stock issuer may adversely affect the value of the Underlying Stock.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>Hedging activities by our affiliates or any participating dealer or its affiliates may adversely
affect the value of the Underlying Stock.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>Trading activities by our affiliates or any participating dealer or its affiliates may adversely
affect the value of the Underlying Stock.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><I>A participating dealer or its affiliates may realize hedging profits projected by its proprietary
pricing models in addition to any selling concession and/or fee, creating a further incentive for the participating dealer to sell the
securities to you.</I></B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risks Relating To The Underlying Stock</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Maturity Payment Amount Will Depend Upon The Performance Of
The Underlying Stock And Therefore The Securities Are Subject To The Following Risks, Each As Discussed In More Detail In The Accompanying
Product Supplement. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>Investing In The Securities Is Not The Same As Investing In The Underlying Stock.</B> Investing in the securities is not equivalent
to investing in the Underlying Stock. As an investor in the securities, your return will not reflect the return you would realize if you
actually owned and held the Underlying Stock for a period similar to the term of the securities because you will not receive any dividend
payments, distributions or any other payments paid on the Underlying Stock. As a holder of the securities, you will not have any voting
rights or any other rights that holders of the Underlying Stock would have.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>Historical Values Of The Underlying Stock Should Not Be Taken As An Indication Of Its Future Performance During The Term Of The
Securities.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>The Securities May Become Linked To The Common Stock Of A Company Other Than The Original Underlying Stock Issuer.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>We Cannot Control Actions By The Underlying Stock Issuer.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>We And Our Affiliates Have No Affiliation With The Underlying Stock Issuer And Have Not Independently Verified Its Public Disclosure
Of Information.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD><B>You Have Limited Anti-dilution Protection.</B></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; font: 12pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt">


<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white"><B>Hypothetical Examples and Returns</B></FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The payout profile, return table and examples
below illustrate hypothetical maturity payment amounts for a $1,000 face amount security on a hypothetical offering of securities under
various scenarios, with the assumptions set forth in the table below. The terms used for purposes of these hypothetical examples do not
represent the actual starting value or threshold value. The hypothetical starting value of $100.00 has been chosen for illustrative purposes
only and does not represent the actual starting value. The actual starting value and threshold value are set forth under &ldquo;Terms
of the Securities&rdquo; above. For historical data regarding the actual closing prices of the Underlying Stock, see the historical information
provided below. The payout profile, return table and examples below assume that an investor purchases the securities for $1,000 per security.
These examples are for purposes of illustration only and the values used in the examples may have been rounded for ease of analysis. The
actual maturity payment amount and the resulting pre-tax total rate of return will depend on the actual terms of the securities.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 90%; font: 10pt Frutiger 65 Bold; border-collapse: collapse; margin-left: 0.15in">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; width: 36%; border: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Maximum Return:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; width: 64%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">31.20% of the face amount per security or $312 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Starting Value:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$100.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Hypothetical Threshold Value:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">$85.00 (85% of the hypothetical starting value)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Upside Participation Rate:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">150%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Buffer Amount:</B></FONT></TD>
    <TD STYLE="padding: 1pt 4pt; border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">15%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Payout Profile</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_003.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Hypothetical Returns</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; white-space: nowrap; border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Hypothetical<BR>
ending value</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Hypothetical<BR>
stock return</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Hypothetical<BR>
maturity payment amount</B> <BR>
<B>per security</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-bottom: #688FCF 1pt solid; text-align: center; width: 25%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Hypothetical<BR>
pre-tax total<BR>
rate of return<SUP>(1)</SUP></B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$200.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$175.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">75.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">50.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$140.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">40.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$130.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">30.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$120.80</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">20.80%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,312.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.20%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$120.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">20.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,300.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">30.00%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$110.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">10.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,150.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">15.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$105.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">5.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,075.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">7.50%</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$100.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$90.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-10.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$85.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-15.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">0.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$80.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-20.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$950.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-5.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$70.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-30.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$850.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-15.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$60.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-40.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$750.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-25.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$50.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-50.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$650.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-35.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$40.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-60.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$550.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-45.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$30.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-70.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$450.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-55.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$20.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-80.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$350.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-65.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$10.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-90.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$250.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-75.00%</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #E0E3E2">
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; border-left: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$0.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-100.00%</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$150.00</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-85.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 24.5pt"><SUP>(1)</SUP></TD><TD STYLE="text-align: justify">The hypothetical pre-tax total rate of return is the number, expressed as a percentage, that results from
comparing the maturity payment amount per security to the face amount of $1,000.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical Examples</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 1. The ending value is greater than
the starting value, and the maturity payment amount is greater than the face amount and reflects a return that is less than the maximum
return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: 0.15in">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid; padding-left: 30pt; text-indent: -30pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; padding-left: 30pt; text-align: center; text-indent: -30pt"><FONT STYLE="font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-indent: -30pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-align: center; text-indent: -30pt"><FONT STYLE="font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-indent: -30pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-align: center; text-indent: -30pt"><FONT STYLE="font-size: 10pt">$105.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-indent: -30pt"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-align: center; text-indent: -30pt"><FONT STYLE="font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt; text-align: justify; text-indent: -30pt"><B>Hypothetical
stock return&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 30pt; text-indent: -30pt"><B>(ending value &ndash; starting
value)/starting value:&nbsp;</B></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; padding-left: 30pt; text-align: center; text-indent: -30pt"><FONT STYLE="font-size: 10pt">5.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify">Because the hypothetical ending value
is greater than the hypothetical starting value, the maturity payment amount per security would be equal to the face amount of $1,000
<I>plus </I>a positive return equal to the <I>lesser of</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.25pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.2pt"></TD><TD STYLE="width: 36pt">(i)</TD><TD STYLE="text-align: justify">$1,000 &times; stock return &times; upside participation rate</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">= $1,000 &times; 5.00% &times; 150%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">= $75.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 12.2pt"></TD><TD STYLE="width: 36pt">(ii)</TD><TD STYLE="text-align: justify">the maximum return of $312.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive
$1,075.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 2. The ending value is greater than
the starting value, and the maturity payment amount is greater than the face amount and reflects a return equal to the maximum return:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: 0.15in">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$150.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return &nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:&nbsp;</B></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">50.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">Because the hypothetical ending value
is greater than the hypothetical starting value, the maturity payment amount per security would be equal to the face amount of $1,000
<I>plus </I>a positive return equal to the <I>lesser of</I>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">$1,000 &times; stock return &times; upside participation rate</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">= $1,000 &times; 50.00% &times; 150%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">= $750.00; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the maximum return of $312.00</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive
$1,312.00 per security, which is the maximum maturity payment amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition to limiting your return on the securities, the maximum
return limits the positive effect of the upside participation rate. If the ending value is greater than the starting value, you will participate
in the performance of the Underlying Stock at a rate of 150% up to a certain point. However, under the terms of the securities, the effect
of the upside participation rate will be progressively reduced for ending values that are greater than 120.80% of the starting value since
your return on the securities for any ending value greater than 120.80% of the starting value will be limited to the maximum return.
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Example 3. The ending value is less than the starting value but
greater than the threshold value, and the maturity payment amount is equal to the face amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: 0.15in">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$95.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return &nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:&nbsp;</B></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-5.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">Because the hypothetical ending value
is less than the hypothetical starting value, but is not less than the hypothetical threshold value, you would not lose any of the face
amount of your securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive
$1,000.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Example 4. The ending value is less than the
threshold value, and the maturity payment amount is less than the face amount:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="2" STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; border-collapse: collapse; margin-left: 0.15in">
  <TR>
    <TD STYLE="vertical-align: top; width: 68%; border-bottom: white 1pt solid; border-right: white 1pt solid">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 32%; border-bottom: white 1pt solid; border-right: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Underlying Stock</B></FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical starting value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$100.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical ending value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$50.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid"><FONT STYLE="font-size: 10pt"><B>Hypothetical threshold value:</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">$85.00</FONT></TD></TR>
  <TR STYLE="background-color: #E0E3E2">
    <TD STYLE="vertical-align: top; border-right: white 1pt solid; border-bottom: white 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Hypothetical stock return&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>(ending value &ndash; starting value)/starting value:&nbsp;</B></P></TD>
    <TD STYLE="border-right: white 1pt solid; border-bottom: white 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">-50.00%</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">Because the hypothetical ending value
is less than the hypothetical threshold value, you would lose a portion of the face amount of your securities and receive a maturity payment
amount per security equal to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">$1,000 + [$1,000
&times; (stock return + buffer amount)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">= $1,000 + [$1,000
&times; (-50.00% + 15%)]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18.75pt; text-align: center; text-indent: -10.35pt">= $650.00</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On the stated maturity date you would receive
$650.00 per security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>If the ending value is less than the threshold value, you will have
1-to-1 downside exposure to the decrease in the value of the Underlying Stock in excess of the buffer amount and will lose up to 85% of
the face amount of your securities at maturity.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; width: 1%; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">
</FONT><FONT STYLE="font-size: 10pt">&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: white"><B>Information about the Underlying Stock</B></FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Underlying Stock is registered under the Securities
Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Companies with securities registered under the Exchange Act are required
to file financial and other information specified by the SEC periodically. Information provided to or filed with the SEC by the issuer
of the Underlying Stock can be located on a website maintained by the SEC at https://www.sec.gov by reference to that issuer&rsquo;s SEC
file number provided below. Information from outside sources is not incorporated by reference in, and should not be considered part of,
this pricing supplement. We have not independently verified the accuracy or completeness of the information contained in outside sources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">According to publicly available information, NVIDIA
Corporation is a full-stack computing infrastructure company with data-center-scale offerings whose full-stack includes the CUDA programming
model that runs on all of its graphics processing units (GPUs), as well as domain-specific software libraries, software development kits
and Application Programming Interfaces.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The issuer of the Underlying Stock&rsquo;s SEC
file number is 000-23985. The Underlying Stock is listed on The Nasdaq Stock Market under the ticker symbol &ldquo;NVDA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Historical Information </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We obtained the closing prices of the Underlying Stock in the graph
below from Bloomberg Finance L.P., without independent verification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following graph sets forth daily closing prices
of the Underlying Stock for the period from January 1, 2015 to December 17, 2025. The closing price of the Underlying Stock on December
17, 2025 was $170.94. The red line represents the threshold value. The historical performance of the Underlying Stock should not be taken
as an indication of the future performance of the Underlying Stock during the term of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_006.gif" ALT="" STYLE="height: 336px; width: 528px"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE
RESULTS.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>United States Federal Income Tax Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should review carefully the section in the
accompanying product supplement entitled &ldquo;United States Federal Tax Considerations.&rdquo; The following discussion, when read in
combination with that section, constitutes the full opinion of our counsel, Davis Polk &amp; Wardwell LLP, regarding the material U.S.
federal income tax consequences of owning and disposing of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, this discussion assumes that you purchased
the securities for cash in the original issuance at the stated issue price and does not address other circumstances specific to you, including
consequences that may arise due to any other investments relating to the Underlying Stock. You should consult your tax adviser regarding
the effect any such circumstances may have on the U.S. federal income tax consequences of your ownership of a security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of our counsel, it is reasonable
to treat the securities for U.S. federal income tax purposes as prepaid derivative contracts that are &ldquo;open transactions,&rdquo;
as described in the section entitled &ldquo;United States Federal Tax Considerations&mdash;Tax Consequences to U.S. Holders&mdash;Securities
Treated as Prepaid Derivative Contracts that are Open Transactions&rdquo; in the accompanying product supplement. There is uncertainty
regarding this treatment, and the Internal Revenue Service (the &ldquo;IRS&rdquo;) or a court might not agree with it. A different tax
treatment could be adverse to you. Generally, if this treatment is respected, (i) you should not recognize taxable income or loss prior
to the taxable disposition of your securities (including upon maturity or an earlier redemption, if applicable) and (ii) the gain or loss
on your securities should be treated as short-term capital gain or loss unless you have held the securities for more than one year, in
which case your gain or loss should be treated as long-term capital gain or loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not plan to request a ruling from the IRS
regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely affect the
tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In addition,
the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of
&ldquo;prepaid forward contracts&rdquo; and similar financial instruments and have indicated that such transactions may be the subject
of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative
contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and
adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-U.S. holders.</B> As discussed under &ldquo;United
States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&mdash;Dividend Equivalents under Section 871(m) of the Code&rdquo;
in the accompanying product supplement, Section 871(m) of the Internal Revenue Code and Treasury regulations promulgated thereunder (&ldquo;Section
871(m)&rdquo;) generally impose a 30% withholding tax on dividend equivalents paid or deemed paid to non-U.S. holders with respect to
certain financial instruments linked to U.S. equities or indices that include U.S. equities.&nbsp;&nbsp;The Treasury regulations, as modified
by an IRS notice, exempt financial instruments issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based
on certain determinations made by us, our counsel is of the opinion that Section 871(m) should not apply to the securities with regard
to non-U.S. holders. Our determination is not binding on the IRS, and the IRS may disagree with this determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will not be required to pay any additional
amounts with respect to U.S. federal withholding taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You should consult your tax adviser regarding
the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments, as well as tax
consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Supplemental Benefit Plan Investor Considerations</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The securities are contractual financial instruments.
The financial exposure provided by the securities is not a substitute or proxy for, and is not intended as a substitute or proxy for,
individualized investment management or advice for the benefit of any purchaser or holder of the securities. The securities have not been
designed and will not be administered in a manner intended to reflect the individualized needs and objectives of any purchaser or holder
of the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each purchaser or holder of any securities acknowledges
and agrees that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">the purchaser or holder or its fiduciary has made and shall make all investment decisions for the purchaser
or holder and the purchaser or holder has not relied and shall not rely in any way upon us or any of our affiliates to act as a fiduciary
or adviser of the purchaser or holder with respect to (i) the design and terms of the securities, (ii) the purchaser or holder&#8217;s
investment in the securities, (iii) the holding of the securities or (iv) the exercise of or failure to exercise any rights we or any
of our affiliates, or the purchaser or holder, has under or with respect to the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">we and our affiliates have acted and will act solely for our own account in connection with (i) all transactions
relating to the securities and (ii) all hedging transactions in connection with our or our affiliates&#8217; obligations under the securities;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">any and all assets and positions relating to hedging transactions by us or any of our affiliates are assets
and positions of those entities and are not assets and positions held for the benefit of the purchaser or holder;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">our interests and the interests of our affiliates are adverse to the interests of the purchaser or holder;
and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD STYLE="text-align: justify">neither we nor any of our affiliates is a fiduciary or adviser of the purchaser or holder in connection
with any such assets, positions or transactions, and any information that we or any of our affiliates may provide is not intended to be
impartial investment advice.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See &ldquo;Benefit Plan Investor Considerations&rdquo;
in the accompanying prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Market Linked Securities&mdash;Leveraged Upside Participation to a Cap and Fixed Percentage Buffered Downside</B></P><P STYLE="font: 14pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: #BB0826"></P><P STYLE="font: 10pt Verdana, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(187,8,38)"><B>Principal at Risk Securities Linked to the Common Stock of NVIDIA Corporation due February 22, 2027</B></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #5E8AB4">
    <TD STYLE="padding-top: 1pt; width: 100%; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Validity of the Securities</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Norton Rose Fulbright Canada
LLP, as Canadian counsel to the Bank, the issue and sale of the securities has been duly authorized by all necessary corporate action
of the Bank in conformity with the indenture, and when the securities have been duly executed, authenticated and issued in accordance
with the indenture and delivered against payment therefor, the securities will be validly issued and, to the extent validity of the securities
is a matter governed by the laws of the Province of Ontario or Qu&eacute;bec, or the federal laws of Canada applicable therein, will be
valid obligations of the Bank, subject to the following limitations: (i) the enforceability of the indenture may be limited by the Canada
Deposit Insurance Corporation Act (Canada), the Winding-up and Restructuring Act (Canada) and bankruptcy, insolvency, reorganization,
receivership, moratorium, arrangement or winding-up laws or other similar laws of general application affecting the enforcement of creditors&rsquo;
rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the principle that the
availability of equitable remedies, such as specific performance and injunction, may only be granted at the discretion of a court of competent
jurisdiction; (iii) under applicable limitations statutes generally, including that the enforceability of the indenture will be subject
to the limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find
any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under such applicable limitations
statutes; (iv) rights to indemnity and contribution under the securities or the indenture which may be limited by applicable law; and
(v) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada and such judgment may
be based on a rate of exchange in existence on a day other than the day of payment, as prescribed by the Currency Act (Canada). This opinion
is given as of the date hereof and is limited to the laws of the Provinces of Ontario and Qu&eacute;bec and the federal laws of Canada
applicable therein. In addition, this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and
delivery of the indenture and the genuineness of signatures and to such counsel&rsquo;s reliance on the Bank and other sources as to certain
factual matters, all as stated in the opinion letter of such counsel dated December 20, 2023, which has been filed as Exhibit 5.3 to the
Bank&rsquo;s Form 6-K filed with the SEC dated December 20, 2023. References to the &ldquo;indenture&rdquo; in this paragraph mean the
Indenture as defined in the opinion of Norton Rose Fulbright Canada LLP dated December 20, 2023, as further amended and supplemented by
the sixth supplemental indenture dated as of July 23, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the opinion of Davis Polk &amp; Wardwell LLP,
as special United States products counsel to the Bank, when the securities offered by this pricing supplement have been issued by the
Bank pursuant to the indenture, the trustee has made, in accordance with the indenture, the appropriate notation to the master note evidencing
such securities (the &ldquo;master note&rdquo;), and such securities have been delivered against payment as contemplated herein, such
securities will be valid and binding obligations of the Bank, enforceable in accordance with their terms, subject to applicable bankruptcy,
insolvency and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general
applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith) and possible judicial or
regulatory actions or applications giving effect to governmental actions or foreign laws affecting creditors&rsquo; rights, <I>provided
</I>that such counsel expresses no opinion as to (i) the enforceability of any waiver of rights under any usury or stay law or (ii) the
effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above. This opinion
is given as of the date hereof and is limited to the laws of the State of New York. Insofar as the foregoing opinion involves matters
governed by the laws of the Provinces of Ontario and Qu&eacute;bec and the federal laws of Canada, you have received, and we understand
that you are relying upon, the opinion of Norton Rose Fulbright Canada LLP, Canadian counsel for the Bank, set forth above. In addition,
this opinion is subject to customary assumptions about the trustee&rsquo;s authorization, execution and delivery of the indenture and
the authentication of the master note and the validity, binding nature and enforceability of the indenture with respect to the trustee,
all as stated in the opinion of Davis Polk &amp; Wardwell LLP dated May 16, 2024, which has been filed as an exhibit to the Bank&rsquo;s
Form 6-K filed with the SEC on May 16, 2024. References to the &ldquo;indenture&rdquo; in this paragraph mean the Indenture as defined
in the opinion of Davis Polk &amp; Wardwell LLP dated May 16, 2024, as further amended and supplemented by the sixth supplemental indenture
dated as of July 23, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: #5E8AB4; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; width: 100%; text-align: center; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><B>Terms Incorporated in the Master Note</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All terms of the securities included in this pricing
supplement and the relevant terms included in the section entitled &ldquo;General Terms of The Securities&rdquo; in the accompanying product
supplement, as modified by this pricing supplement, if applicable, are incorporated into the master note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp238987_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.2b -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: cd97fb10c5efa7ad383a3a11a2e338ba -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001000275</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="fee_004">333-275898</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_007">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001000275</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-12-19</xbrli:startDate>
          <xbrli:endDate>2025-12-19</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_008">F-3</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_009">ROYAL BANK OF CANADA</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-40">2,564,000</ix:nonFraction>.
<ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-41">The prospectus is a final prospectus for the related offering(s).</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  ] (0# 2(  A$! Q$!_\0
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M63=KI1>S<NC=FFNS05(TY1A.*UNONNUV1Z]1117:=A%<16]Q&8;B.*1&ZI(
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+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &< J$# 2(  A$! Q$!_\0
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M!UVMG%2UYO#-)!*LD3E'7H0:[K2=0_M&Q64@"13M<#UJ)0L:0GS:%ZBBBH-
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M )YM^=']I)_SS;\ZS:KW=]9V"(]Y=06ZNX1#-($#,>@&>I/I1[68&U_:2?\
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M],<5%<V+VR*Y>.1&8KN0G 8=1R!1="LRM73>$B=MV,\#8?YUS-=-X2_Y?/\
M@'_LU3/X2Z?Q'2T44'D=<5SG4%%>=1W>O1ZCK/AR;Q->'5FGA?3IC!; BW8$
MEMOE8.-LF[/]T8VYK;E\;Z9IK^3=F[DMX_,B_M(K&T4TL2%I$&PYW *V?E"Y
M! .1BCI?^OZZ>H=;'545F:)K!UJU>?\ L^[LP& 47/EGS%(!#*T;LI'/KVK3
MH:L 4444 %%%% !1110 4444 %4-3_Y9?C_2K]4-3_Y9?C_2LZOP,#/KB?&%
MC::5K6F>+5TZ*XF@D^RW.(U+LD@VJ03W#;1GT8]J[:L[6="L-?M5MM12:2%7
M#A([B2+)'()V,,X.",]^:XXNS3&<O:I/X?NQX?T"UTVSF6U;4KN22 E)&9L;
M5"LN.01G)V@ 8-5CXVUBXTC4M1MDL8UATRVU&".6%V(#[]R,0XS]SAACKT-=
M=?>'M,U%8!=0RNT">6D@N)%<H>JLX8,RG R&)![YJ/4/"NBZG&([FR&SR?LY
M$4CQ;H^R-L(R!V!Z'D8K12CUU_K^D(A\2ZK?:18V=];R6J6PN8DO&GB9]L;L
M%W+AAC!(ZY_2L0^)=8O].NREKIQEM([AKRRN$?YX\!HL-GC<C#.5(.".*ZZ?
M3+.ZTLZ9<1&:T:,1,DKLQ91ZL3DGW)S4<^BV%R+SS("#>Q+#<-'(R,Z $ 94
M@C@GIBHNK- M+7//M<=;BRUZ;R8H_-\-6SE$7"K\TA  ]!VKL_$>I7^EZ=8S
M6!MM\MW!;N)XV8%9&"\888(R#WZ=*@;P'X?>.6-X+QDE@6V<'4;@[HE.0G^L
MZ#^I]36EJ.@Z?JMA!97BW#P0,CQ[+J5&#+]TEE8,2.O)///6K<HNWK_F+7\/
MT1RG_"8ZU'JGV%K-;F:SGBM[V.UT^X=7+X+.DHRJ*JL#A\DX/3@ER^--6BT5
M_$,UC#)I$L3M"(4;S(G\P)&K_-E]V23M4;<8Y-=3/H.G7%^E[+%(9E4*<3R!
M9 .F]0VU\9XW U%#X8T> W/EV?[NYW>9$TCM'\WWMJ$[5SDYV@9[U-XVV_K^
MON'U_K^O\SF8/$FK7>HV%M>:7;NIO_)BOI[&:WY,+,&CBE&X$892=WTZ\(?%
M^L6>FSW5\UB\NG/<#48(+5\@(0(]A,AQNW*<G.03Z<]%_P (CH^;5C'=L]K*
M)8G:^G9@PX&6+Y8 $@ Y !/J:T!I5B)[R<6L?F7JA;DD9\T 8 /X'%-RCV_K
M^OT&9'AK6M2U5KZ&]MV7R0C171L)K5)-P.0$E^8E2.2#@Y'2L73O&.K16FGW
M^KBREM;R>>VV6D#I(CQE\-\TC;@1&>,#&1R:Z[3](M-)A=;))"S#&9[B24X'
M1=SEB%'H.!GI6!X0\(G2(?/U2WA;4%GFDC>*\EGC02,6)57"JAYP=J\XZ\XH
MO'7^N_\ P">AD#QUK4VC7VH6UFOE+8_;H)9].N(HTP1^Z9F($A*G(9#C@\$5
MUDESKEKH-W<2PVMS?H6:&.U5MK)GY<ACDMCJ ><<8IDG@_1);2YM'MIS;W *
MO']KF 52<E4^;Y%)ZA< ]Q5Z?2+.YTH:9,)GM@% S<2>9\I!!\S=OSD#G.:4
MG&VB'U..?QQ>"WMK6*2.;49FF;S(](N6"+'MRCP F1'RZCDD <]P#9L_$_B'
M69B-/TR&W>V2V^UVMTC"4-* 6P2R[0BG/();&.*WF\,:4UHEN8K@!)#*)5NY
M1-O(P6,H;>3CCENG'2G'PSI!O([L6FR9$$>8Y70.HZ!U! <#)/S ]:=X]OZ_
MK_,1B:5XAUB\ET83M8!;Y;I)=D#@K)$6 9<N?E.!\IY]ZI1Z]K]QI.F:AJ%G
MHMS:7-W;Q8".KQ.9BA<*Q8''RD<C'/7%=)_PB>C"^2\2VECFC=I$\JYE149A
M\VU58*,]2 .3R>:C'@[11I46F"*[^R13BX1/M\^5<'((;?GKSC.,\XS0G&]V
M%F<S!JOB?3M*U#47U+3[BUM]5ECG$MG*SQQ>;M9E/G=%!R%QP!UKJ=/N-;N[
MA9S)ISZ>UQ*,K&ZR&$#"$?,03N')X!&,"B^T-1!=Q:=;0+_:)*7?FS.$ 8$,
MZQX*ESGG[N>YXJX-&L%?3V%N VGJ5M<,1Y8*[3P#@\<<TKJW]=ARU9S_ (V@
MOV-K.L=Y<:;&5$L%A<F&;S#(FU@0R[AC<,9ZD'GL^'Q%-&_AB*S(O-.U/]W]
MLN7(G)$;MR@4#/RC)SZ\=ZUM7\/6.LR12SB6.:,KB6&>2)BH8,5)1AD<=^AY
MIEUX5TB\EL9)()D-@ +58+J6%8L#'"HP&<$C..G'2B+5DF#&:WJM[!JFFZ3I
MWV=+J^\Q_/N4+I&D8!/RAE+$Y  R.Y[5C6_BS4]0N+;2;>.SAU-[JXMY;B16
MDA AQEE0,"2VY?EW<<\G'.K!X1T[[--%<0ME[R2\0PSR(T+OU*."&7/?! Y(
MZ59D\,:/)806?V0QQ0.9(FBF>.1'.<L)%(?)R<G.3DYS0G%+4'Y&#;^+-3U"
MXMM)MX[.'4WNKBWEN)%:2$"'&65 P)+;E^7=QSR<<Z^C:W<:EI%_+.((;JQG
MFMI'4%HBR?Q 9S@C!QGCD9[U/)X8T>2P@L_LACB@<R1-%,\<B.<Y82*0^3DY
M.<G)SFJVL:).GA&[T?P]#;0R3QO&IGE957?G<Y8*Q9N2>>IZFDVFK+^OZ[#6
MZ,2T\8:K%:6%SJJ6?E7>DRW[+!&RM"4"GDECD,&'&!@CJ:CT_5K_ ,-Z--9%
M+>5=/T:.Z*^60WVARWRD[L$%@>@&*W[#PAI,.D26DUCS<VX@N%-U+-A,?<1V
M.X(.P&T>PJ2^\'Z%J1)O+)I6,:1EC/("0IRI)#9+#G#'YAD\\U;<+OL)/1%-
M==U1?%%OI=PEM;QN!M$D,G^D?)N9HY 2H(.1Y9YP,YILCZH_C^Y@%]#_ &>-
M.21K9H6.<LXX._ ;(Z[3Q@8[UK6WA[3+.^^VPP2>=DL-\\CJK$8+!68J&(ZL
M!DY.34MYHUC?7*W,T<BW C:+S89GB8H>JDH02.<@'H>1@U#:>WF-/]/T.$T+
MQ3<>&_">F"]ABGM?[':[A$"$.GEE%VMDD-G>#D8Q@\'K74>&-:U'5)+R*_MG
M AV-'<_89K5)0P.5"2\Y4CDYP<CI3[;P9H5H]JT5M/\ Z+ UO$KWDSHL;?>4
MJSD$'W!Z#T&-#3]&LM+B>.U68!QM+2W$DK #H SL2 .P!P.U7.47=B?D<#I_
MB:XTC2;?3-.A8W3R7UP/] FN5*K<. @6+E221\QX'OD"MV'Q-J\FL6<5Q:)8
M6]S&C1P7-K)NE9H]Q43 [4<-\NQER=I.>>-2+PAHT%E%:10W*1Q2O+&RWLXD
M5F^]A]^[!ZD9P?2GCPIHXN7F%M+\W6+[3+Y0.W;D1[M@.!C(&:3E%_UY!_7X
MG,#QSJ%M9R+?+&E_)-%!';+IL_F6SONR70,3*H"G#1GYB.U3Q>(_$]Y]@@MK
M:SM[FX:YB'VZSGB#M&,I(%+!E5AV()'J:Z"+PKH\5G-:^1-)',%5FFNI9) %
M.5"NS%EP>1@C!Y'-+_PB^E?:;.X\NY\ZS8M%)]MFW9.,ECO^<D  [LY''2B\
M;[ _(KZOJVHQ:OIVC:?]ECO+J&2=I[B-I(T5-H("AE))+#N,#UKG]+U75->\
M6Z->B2U@C^P7.^ PL_S),B/M;>.I (..!G@YX['4M'L=76,7D3EHB3')%*\4
MB9ZX="&&>^#S5=/#.DQ7UK>16\D4MK"8(1'<2(BQGJNP-M.>^1S@>@I1:7X_
MK_7X@]K(O:?]M^P0_P!I?9_MFW][]FW>7G_9W<X^M6:K:?86VEV$-E9Q>5;P
MKMC3<6P/J235FI>X!1112 **** "KNFG]ZX_V:I5=TW_ %S_ .[6E/XD!I44
M45V@%%%% 'G=[_Q_W/\ UU;^9J"I[W_C_N?^NK?S-05U+8XGN:)U"W*VR_9I
M1Y"E01/@\]\A>#FHI[]I;Z*Y"8:/;C>=Q;'<GC-4ZTVTN..T,TEPX(C20JL6
M1ANG.11HM1J[T&_VA;[)U^RR8FD60_OAQ@YP/E]S4TFN,Y?"3(I<NH2<K@GJ
M#@<C/X^](VC)]H>**X>5HQND"PG(& 1@9YSG% T5C=-;[Y=V 5;ROEY&1N.?
ME/MS4^Z5[Q6L]1>U26/]YLDP3Y<FQ@1W!YJ=-6C4Q%K>1FCF,V3-G)Z=P3V%
M TZ*>"Q6 OY\V[=E>#@\GKV^G-..C*AS)/)&AB:0;X<-\IP01GBAV"TA(]7C
M66*1[5F,);R\2XX;/!XYZ^U)#JEO"L*BUD/E!PN9AR&ZY^6F65M:27-RCR-)
M&D3,CJF,X'7&1^567@%]86,?VAO, E$>]?O 'N<\<#WH=@7,Q;.]AD555?+,
M,+(!),O[S)Z<C'YYJAJ6S[7O28R,RAG)8-M;TR, _A3ET\-8&ZWRJJ[=VZ+
M()Q\ISS^E/N],6W2<QW'F& KO!3;PW3')HT3%JT*=79KL3M",^5L.UL')ZL#
MC@TLVJQ2K/FV<-+$L9/FYQMZ'I["E@CAAL[2YC>1+@S%<@=>G'7W]*DO=-:Y
MOY7MY-[/<F-E*XVGK^(ZT:7&N:UQG]L@>8ZVY6=V5RXDXW+[8Z>V:K7U^;S'
M$H&XMB28OCV'H*6_TYK)(GW.5DR!YD>Q@1[52II+=";DM&%=-X2_Y?/^ ?\
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M2?E&1][YC_=SQ8\%I=)/XB6]D@DN!JC;W@C,:-^ZBP0I9B.,=S5*.C?]=/\
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MM_S[Q?\ ? H^R6W_ #[Q?]\"IJ* (?LEM_S[Q?\ ? H^R6W_ #[Q?]\"IJ*
M(?LEM_S[Q?\ ? H^R6W_ #[Q?]\"IJ* ,&U\*:?#=R7,Z_:'=RX5AA%R<XQW
M_&KVHJ%6%5  &0 .W2M"J&I_\LOQ_I45FW%W SZS;[21<ZG::E!-Y-Y;*T88
MKN5XV(+*1D?W00<\$=^0=*BN%: <]_PB%BD<=K TJ6/VK[9-"\LDIEE#!@=S
ML<+N&2 .3^.>AJLFI6,C(J7MNS22-$@$JDLZYW*.>2,'(ZC!JS3;?4.HV6-)
MHGBE0/&ZE65AD$'J#6+8^%-,L&NC$+C]\"BL;J4M"A5051BY*?='W<= .PK<
MJM_:%E_:']G_ &RW^V[/,^S>:OF;/[VW.<>]"OT Q8?!VFV3::EC%)'#97+7
M*>9=2R%6*D$+N8X!W'/;KQDYJY;^&-'M+\7D-H1*KM(BF9VCC=OO,D9.Q"<G
M)4 \GUK7HI\S R+?PQH]I?B\AM")5=I$4S.T<;M]YDC)V(3DY*@'D^M%MX8T
M>TOQ>0VA$JNTB*9G:.-V^\R1D[$)R<E0#R?6M>BE=@1/;023K.\,;3(I17*@
MD*<9 /H<#\J@FTNRGTLZ:T 2S*!/+B8Q[0.F"I!'X8J>>Y@M55KB:.)6<(ID
M8*"Q. !GN3P!4M(#(3PQI*1(@@E+I-YZSO<R--OQC/FEM_3CKTXZ<4Z+PWI,
M.H&^2TQ-N9P#(QC5V^\PC)VACDY8#)R>:U:*=V!S\G@G0)+3[(;6=;<.)%C2
M\F4(0<@+AQM7(!VC R <9 K1L]&L=/:\:TB>+[8_F3!97P6(P6 SA2>Y&,GD
M\U?HHN]@,>#POI-MHYTJ.&?['O\ ,56NY69&SG*N6W+SSP1SGUJ:/0--BEMI
MD@<36V=DWG/YA!ZAVSEP>"0Q.2 >U:5%%V!ACPAHJ7:W4=O-%*@D5/*NY45
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M!</<Q%K^=@LK?>;!?!SSD'@Y/J:O:3I*Z9]JE:7SKJ\F\ZXEV[0S8"@ 9.%
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M?=8=5^E8$GA28.?*N8RO;<"#74T52DUL2X)[G)_\(I=?\_$/Z_X4?\(I=?\
M/Q#^O^%=913YY$^SB<G_ ,(I=?\ /Q#^O^%'_"*77_/Q#^O^%=911SR#V<3D
M_P#A%+K_ )^(?U_PH_X12Z_Y^(?U_P *ZRBCGD'LXG%7^@3:?92W4LT;)&,D
M+G/7%6?^$4NO^?B']?\ "M;Q-_R+EY_NC_T(5K4^=V#V<3D_^$4NO^?B']?\
M*/\ A%+K_GXA_7_"NLHI<\@]G$Y/_A%+K_GXA_7_  H_X12Z_P"?B']?\*ZR
MBCGD'LXG)_\ "*77_/Q#^O\ A1_PBEU_S\0_K_A7644<\@]G$YZS\+Q1N'NI
M?-Q_ HP/Q/>N@ "@   #@ =J6BI;;W*44M@HHHI%!1110 4444 %%%% !111
M0 4444 %%%% !4%U!Y\.!]X<BIZ*35U9@8)!!((P1VI*VI;>*;EUY]1UJ'^S
MX?5_SKE=&70#+HK4_L^'U?\ .C^SX?5_SH]C(#+HK4_L^'U?\Z/[/A]7_.CV
M,@,NBM3^SX?5_P Z/[/A]7_.CV,@,NBM3^SX?5_SH_L^'U?\Z/8R RZ*U/[/
MA]7_ #H_L^'U?\Z/8R RZ*U/[/A]7_.C^SX?5_SH]C(#+HK4_L^'U?\ .C^S
MX?5_SH]C(#+HK4_L^'U?\Z/[/A]7_.CV,@,NBM3^SX?5_P Z/[/A]7_.CV,@
M,NBM3^SX?5_SH_L^'U?\Z/8R RZ*U/[/A]7_ #H_L^'U?\Z/8R RZ*U/[/A]
M7_.C^SX?5_SH]C(#+HK4_L^'U?\ .C^SX?5_SH]C(#+HK4_L^'U?\Z/[/A]7
M_.CV,@,NBM3^SX?5_P Z/[/A]7_.CV,@,NBM3^SX?5_SH_L^'U?\Z/8R RZ*
MU/[/A]7_ #H_L^'U?\Z/8R RZ*U/[/A]7_.C^SX?5_SH]C(#+HK4_L^'U?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',>)-4<2&QA8
MJ /WI'?/:N;JSJ#E]2N6;J96_G5:NF*LCCD[L****HD**>(93"9A$YB!P7VG
M /UIE !1110 44^**29]D4;R-_=5<FAHI$4,R,JDD D8!(ZT ,HHHH ***>L
M,KQM(D3LB?>8*2!]30 RBBB@!58JP920P.01VKM="U(ZA:%93F:+ 8^H[&N)
MK<\+.1J<B]FB.?S%1-71I3=I'7T445SG4%%%% !1110 4444 %%%% !1110
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MH&5TE<%"N(D+'MV%3+8J'Q([FBLK^W[?_GVOO_ 9O\*/[?M_^?:^_P# 9O\
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M'.#VS4'_  FEE8WRV%T+V=([".Z:]BL9G#[L\[4C( P,YSCDCM4INUOZV?\
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MJ P.>00N/4UU5%+F_K\!_P!?E_D<EX>TZ_LO#]T^F36\TC.R:<;D,(UMPY*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%<E#XLU-FO;6;1K:*_B$GV:+[<3'<&,_.-_EY4[2I V
MG.?8UI6?B.V73M-EUJ>PTN]OU#16KWBDL3T52P4L>1G ZGOUH6H,VZ*** ,_
M5ONV?_7W'_.M"L_5ONV?_7W'_.M"F]A+=A1112&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 <'-I>M:YI6LQG2KC2;^*\:[TNXFEA?<VW !V.V <%6![-U]*NI^&]
M8#:HJ:8+\:MH\-@K&6,"T=58'?N(.S+!LIN.1TZ&O1J*.EOZ[#O9W7]:W*]A
M;M::=;6SR&1H8EC+G^(@ 9JQ113;N[DI65D9^K?=L_\ K[C_ )UH5GZM]VS_
M .ON/^=:%#V!;L****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\Z:W W:***ZA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 4=3_U<?UK,K3U/_5Q
M_6LRN>?Q#"BBBH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "I+?_CYB_P!\?SJ.I+?_ (^8O]\?SIK<#=HHHKJ$%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!1U/\ U<?UK,K3U/\ U<?UK,KGG\0PIJNKC*,&
M&2,@YY!P?UJIJ\5]-H]W%ILJQ7K1,(7?H&QQ7&Z'J4FFV&LK:PZA_:-JCS-9
M:G>,\142/^\23#GG!!&>2O09),=&^P['?T5D)K1C\(+KEQ%DBQ%W)''W^3<0
M,UA/XKU/25M9]7CLYX;RRFNXULU96B,:!]A+,=^0<;@%Y'3FFU9M/I_P?\A1
M]Y)KK_P/\T=I17%OXKU/25M9]7CLYX;RRFNXULU96B,:!]A+,=^0<;@%Y'3F
MK>G:[JRZGI-MJ@LI$U6!Y8OLJLI@*J&VMECO&#]X!>1TYI\KV_KK_D*^E_Z_
MK4ZFBL#6/$\&E:C:6A@O7,DVR4QZ=<2C;Y;-\K(A#'(' SQGCCBMXR6WU#P_
M8++#YEO/J%GNBGB(W*95X9&&?J"*23=O,;T.G9U4J&8 L<+D]3Z"EKA?%=I-
MI]S9RK#>KHD"!(XM)E\E[9@K[GV*0'&-N!SC:?E.>=B/7;C^W](T^)(IM/OK
M-YX[MG)E?:%ZKM 7.X'.3]!1:^P/0Z*BL+5]5ODUNQT;33;17%S#).T]S&TB
M(B%1@*K*226'<8YZUCV'BO5=;NX=-L8[*UO56X:XFG1IH_W4GEX10RDY/.<\
M#UH2;#8[6BN+L/%>IZ])96>G1V=I=R0S2SR7"--&OE2>40BJRDY;G.>!V.:W
M-!UF;6_#ZWZP1QW&9(S&7^3S$8H<-C[I*]<=*&FE<#8HK%T+Q ->><PV_EQ0
M?)(7<%O,[A0.J^C=#VK,BFGNO$GB*Y$ NI]+2..QMV(P',18D9Z%MVW/H,46
M#<ZVBO.GUO7]2O\ 14BU2T@E_M%HI8CI\\+#]P[!9(VER1P<<D'Y2.F#H?\
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MBA1O_7=-_H#>E_7\#T"BBBI&%%%% !1110 4444 %26__'S%_OC^=1U);_\
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\\C^8K:HH]F@,7[%<?\ /(_F*/L5Q_SR/YBMJBCV: Q?L5Q_SR/YBC[%<?\
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@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &! G8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&.U22<8&<UXU;:[K4%
MM"[:G>H=4MXR]U-,SI<"2ZBC^T6RD?N56.7[I"'YE^5MNX^S5@V_@OP[:QW4
M4>F1F*YC,3QN[NBH6W%(U8D1KN.=J;1G!["@#DKC^UEN-5T^T?5+BQTF]Q%,
MFH,KQ%H$D#2R.X:6-&9B5)8D,HVMC Z7P_XC^W:E/87D%Q!?2;IU1]I0*NP-
M&I#$Y3<F[( +,=N1TU;;0M/M--:PBBD\AW\R3?.[O(V0<N[,6;H!R3D#'3BG
MPZ/80:M/JD<!%Y.H1Y"[$8X^ZI.%SM7. ,[1G.!0!E^+/&5EX-M[:ZU&RU"6
MTFDV27-M!OCMN5 :4Y&T$L,=<UT5>?\ QM_Y)#KO_;O_ .E$=>@4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,>6
M.,H))%4NVU=QQN/H/4\&J8UW2&U8Z2-5L3J0ZV8N$\X<9^YG=TYZ=*SO$%G'
M+JWA^[=YM\%]A$$A"9:-\DJ.&.!@$],G'6N-U:XO8;77M+T346O=8OY[TW-B
M(@DMNA@?RW !+#E(55R<,&& ": /0/\ A(M$_L^?4/[9T_[%!)Y4US]J3RXW
MR!M9LX!R1P?45?26.1MJ2(QVAL YX.<'Z'!_*O.+.*#5M5NM1T&^M+72[/3K
M0">6#S8(YHS+E'3<O*1N,C(*DKGIBKFAZAJ&E^)-/TB4PS+=P+\A0B:.%4<Q
MN/FP$4*JL"/OR$Y P* .^JM9ZC8ZB)C97EO<B"0PR^3*K^6XZJV#PP]#S7'Z
MCXAU&#Q#=:?'>E+[[?;)9:>8T N+5MGFR#(W-MS,2P.%V#(]=#23<6?PZ$L-
MT_VA;-Y(Y7A\S8VTD'8BY8 \X )/O0!U#,JXW,!DX&3U-+7E$_B2+4KS09[C
M6"T5GJD?VB\AN;>:S0O#.H"S+&OS?=R&48WKQR#6G_PE.HN6^S:DTXAM'?5<
M0H6TZ42QKC:%R"%,Q"MNR$!Y'4 ]!:6-94B:1!(X)5"PRP'7 [XR/SI]>?ZS
MJ]S,NFWWAV^34EC6Y\R\< _N@8S(T6U DC 9"_PDCDG!!UK_ %2]E\0Z';Z9
M?E[2YT^YNOE5"+DIY/EY8C@'>>F.OTH ZDD*,D@#U-+7CLFOZQK.B1G5-2LD
M:UGLIK^&WN!)):N+F/=YBF!1"!\YVLS'Y>I 8F[KWCG4[#2)+>'4U368;O41
M-%Y2%XXDBN'@W+MPH(6)E)^\!W&: /5:*X6XU+6(;S54&KSE;'2;>[0>3%\\
MCM-NW?)T(11@8X]^:ZG4[T_V%J-Q8748FABE"RHAF$<B@]54$D@CE0">,8H
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M7?\ MW_]*(Z] KS_ .-O_)(==_[=_P#THCKT"@ HHHH **** "BBB@ HHHH
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MH1EWP,[5!(R3T%35@>-=<7P[X1U'46>YC*0LJ2V\/FM$Y!"MM/! ..O'KQ0
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M$TNP,P9A%O;RPQ!(+!-H)R?J:U* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "H;NT@O[.:TNHEEMYT,<D;=&4C!%
M344 8NCSW%E<-HM]YC-"@-I=2/N-U$ ,DG^^N0&]>&[D#:JCJNF1ZG:A"=EQ
M$3);3C[T,F" P_,@CH02#D$TW2=0DO8'2ZA6"^@(2YA5]P5L Y4]U(.0>/<
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M3Z?ZZNV74FOFN[>QCD62(,@GFB(CW@XQV+?AQQ4MOIJ(T,]T_P!JNX@0L[H
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MJ]#HH]HOY5_7S#V+_G?X?Y'GG]K_ !0_Z%S2_P#OXO\ \>KHO"]YXHN_M?\
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M8XR!FM2VT+3[336L(HI/(=_,DWSN[R-D'+NS%FZ <DY QTXI\.CV$&K3ZI'
M1>3J$>0NQ&./NJ3A<[5S@#.T9S@4 >>?'K68K'X<W.FO;7,DFHLBI+&@,<6R
M6-SO.>,C@<')KU&O/_C;_P DAUW_ +=__2B.O0* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5C^(O$VG>&;#[5?R_,V1%"O+R'T _KT%4/%OC2R\+VZIM^TW\O$5LC#(.."W
M<#I]:Y'P[X:U#5;Z+Q+JVS4[Z5R$B=QY-OCH7ZYQGA5& >O/36,%;FGM^9A.
MHV^2GO\ E_78ETO1;_Q?='Q)XL)32$0SVMEO^4+UR0.V!GU/TXKMFEO-2T^V
M&C;;*V8E6DEB*LB#&/+3&.??%7+?3(XK^6^DEEEFD&T*[Y2,<9"CL.*O5,YN
M7H73IJ"\^Y5@T^UM[J2Z2%?M,H DF(^9OQ_#H*M445!H%%%% !1110 4444
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MHST% 'G?QWU+[+\-+VQ^Q7DWVPQCSX8MT4&V6-LRMGY<]!UR>*].KS_XV_\
M)(==_P"W?_THCKT"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *BN;J"RMI+FYF2&",9>21L*H]S7(^)?B+
MIVAW?]GVD+ZCJ.<>3"?E5O0GGGV /X5EVO@W7_%$\5[XOU$K:[O,7383@ =@
M<8 _4^]:JGI>6B,)5M>6"N_P7J7+WXM^&[2Z>%%O;H+QYL$2[#]-S _I5?\
MX7'X>_Y\]4_[]1__ !==AI&FZ?I+3VFG6\%O$NPE(I23G'5E/W3[]ZTZ?-3_
M )?Q%RUOYE]W_!///^%Q^'O^?/5/^_4?_P 71_PN/P]_SYZI_P!^H_\ XNO0
MZI:EJEMI5N);AF)8[8XT&7D;T4=S1S4_Y?Q_X <E;^9?=_P3B?\ A<?A[_GS
MU3_OU'_\73+GXGIJL0LO#UA>#49R%B:YC7 '<@!B6/MT[GI7;*E_=7>^1XXK
M QX$(!\UB1_$>-N/;\Z2"QL]-FMX+2*&!69CM$I4L<==O\9^O3K2YH=(_B-0
MJ]9?A_P3F?"W@864[:QK;_:]5N58RB10RJ6ZCODXXXP.U=LJJB!44*H&  ,
M"EHJ)2<G=FL8**L@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S/$G_(KZMB=;
M?_0IOWS.R"/Y#\Q902,=<@$UIUD^)=8AT+P]?7\EY:6CQPN89+MB(S(%)4$#
MD].BY)[4 >=?#_QU?W=_I'AZXUSPS?JL7E%[::Y:YEV(<-\\84GY<DD^M>MU
MY#X:U_5]<\8^'+K6O$GAN5)(YFM+?13*TLI:+)64.,HH W8/\2@=:]>H ***
M* "BBB@#S_XV_P#)(==_[=__ $HCKT"O/_C;_P DAUW_ +=__2B.O0* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **I:K
MJUAHMBUYJ-RL$"G&YLDD^@ Y)^E<)+XO\1>+9Y(/!UF(;-/DEO;H ')],DX_
M(GZ5I&FY:]#*=6,-.O;J=5XA\8Z-X;C87MR&N ,K;1?-(V>G';ZG%<EY/B_Q
MZRBY#Z#HV,E5)\R8'IZ$_C@?6MGP]\.].TJ=+_49'U/5,[VGG)*AO4 ]3[G)
M[\5V57S1A\&K[_Y&?).I\>B[+]687AWPCI/AFW"64 >?G=<R@&1L^^.!["MV
MBD9@JEF(  R2>U8MN3NS>,5%62*T ;[?=$A]I"8)10IX/0CD_CT[4^[O+:QM
MVGNIDAB'5G.!67:W@?Q%J4$$&7*Q[IP#M7Y3C=DX/MM]\U;@TPLD3ZC*+VXC
M?S%9HP%C;'\(';ZY-(H2.ZO;J^DBCMO*L@F5N68;G)'&U?;WKYQT/X@>+O"7
MCW4O#EO;OKH_M&6**VN23)D,0#&W\.0/<8[5]/USJ^"-$AU'5-2M[?RM1U&1
M99+L8+HRX*E,@@#<H;'0GKF@#9T^>XN=.MY[NT-G<R1JTMN9 YB8CE=PX./4
M4DX8WUH0'V@ON*HI X[D\C\.M5=%U)[M9K*[=/[3LBJ72HI4$D95U!_A8<CD
MX.1G*FGWFS^V-,W>5OS+MW%MWW>=N./KG\* -&BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "LOQ)!;7'AO45N]-34HEMW<VC#/G%5)"CT)(X/8UJ5ROCK5
MKG3++2HK;4!IXO\ 48[66[PA,,95F)&\%0?EQD@]: /._A7XDAN=6L[5-*T5
M;B:::)TL;=8Y;.%8(G0D_>*AB\9+')8]>"*]NKS#P3J.L:WXCFDU'Q#8?8[*
MYF@MHK4Q+/J10NGFS!?X0.0% !/., 9]/H AN+NWMBBS7$,+2';&)' W'T&>
MM>973:OI2W)LM=OKR)Q!97^HS2DQM<S7*(6@0DB+8CR A<*"4')4X]290RE3
MT(P<'%<_9^"="LK)[*.&\>S:'R#:W&H7$T(3C@([E1C P0,CMB@#EIAJHN=5
MTRUDU2XL])O,0RIJ!5XR\$<BF5W<-)&C,Y*DL2&4;6 XZ3P]XD&H:G<6-U;W
M-O=R;KA$EVE H" H,$D,NY-P( W,<9P36K;:%I]IIK6$44GD._F2;YW=Y&R#
MEW9BS= .2<@8Z<4^'1["#5I]4C@(O)U"/(78C''W5)PN=JYP!G:,YP* ///C
MUK,5C\.;G37MKF234614EC0&.+9+&YWG/&1P.#DUZC7G_P ;?^20Z[_V[_\
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MR4267R\9Q@N<]>,X !OT5P%AXMU^[^TPO#;122&U>SFFM#&ICFE*;C&)V<C
M!&[RR>ZCMHVVM:]%)!+>R:=+;B[ELI8X+9T>1E#D2*3(0H^4#80W<[NP .NH
MKD[3Q!J@6/[6UE,;C[)-&T$+(L<<\FS8<NVYACAN ?[HQR2:SK=]=O;:;/IU
MNR&Z)DN+9Y@1%(J!<+(F"=W)SVZ4 =917%^%-4UG58/$=Q/>0;Q,ALU,#%;<
M-;1R $;_ )@-XZ;<D,>,@#*\/>)=9C\-V)>YM9GM=,MK^\>Y61I+L3%OE0E_
MD8;<9.X$D *HXH ])HK \+:KJ.LP7UU>FU6&.\GMH(X8V# 1RNFYF+$'("\
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M*>ZNK9;"V$UG(N][LOA .>%'4GBI+#2H[*ZN;IIYI[BX/SO(W0#HH X &:O
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M^/DZ#ICH*AL-.:TU6ZG$:)#);P1J%]4W@\?0K6I0!%;VT%JC);P1PHSLY6-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"E?ZOIVEF%+_4+2T>X;9 +B98_,;T7)Y/(X'K7FD7C773
M::6?M<HDU&UB<RSVRK'E[J&+S(,*/E"R,<2<X*'!YSZP1D8-84/@[0($GC33
ME:.9#&8Y)'=8TSNVQAB1$N0#A-HR >PP 8;:IK[:CK=E!<3S1Z9-A9U6!6.Z
M".11)N &T%GR5 ;&WWK9T/Q$NH7LEG<K)#=N9)8H6486-2HVY'\0#H6!Z,Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >?\ QM_Y)#KO_;O_ .E$=>@5Y_\
M&W_DD.N_]N__ *41UZ!0 45G:IK$.F-!$8II[B<D10PKEFQC/L ,BA["YN;Z
M9KJZ#6#Q^6MHJ8!R.2S=3WH CN-7>5$&D0K?.\A0R*X\J+&,[C^/059&G)_:
M+7LDTTCE2BHS_(BGJ HX_$Y-6(((;:%88(DBB485$& *DH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S[0(-8U$@
MP[B(MP1V+CY3C<#P/;'7O6A5:$2B^NBXF\L[-F]E*=.=H'(]\_A5F@ HHHH
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M"0A#@X;DD8SS6T-0LC?-8B[MS>)'YS6_F#S%3.-Q7.=N>,]* .(_X7;\//\
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ME;1K:6W1 HQ('CV$D]B!S0!F>$OB ;_PSIUWKEM-;W-S837WF[8Q%*L1&\(
MY(P&! 8 X!KL=+OQJNE6NH+;SVZW,2RK%. '4$9&X D X]Z\QUOX;ZHVE^&/
M#%C)+=Z;9W;23:C+*D3V]OC:T.Q0"X=689]N>#7K(    P!T H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JK]CSJ8O6GE;;$8DA.W8N2"6'&[)PHY)'' '.;5% &=HVC6^A
MVT\%L\KI-<RW+&0@D-(Y9@, <9/%:-%% !1110 4444 %%%% !1110 51O\
M2TU&XM))KB<0VT@E^SKMV2N""I;*[OE(R,$#/7-7J* "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ JK>V$=_]G$SOY<,RS>6N,2,O*[LC. V&XQRH[9!
MM44 4(M)@AUVYU=7D-Q<6\=NZDC8%1G8$#&<Y<YY]*OT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
944 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_006.gif
M1TE&.#=A$ )0 7<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MYYT.(LD1/TRTZ4\^WQW!SP--#%'? TR T42B"( A$ $QXBGII/D%@.-&33C
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MC A'2,(2FO"$*$RA"E?(PA:Z\(4PC*$,9TC#&MKPACC,H0Y7B( @<80$Z0(
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MB!VL81>;V,,JMK&,?:QD'4O9R%86LIB=K&4WF]G+:K:SG)4K/4@*/51)\@@
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M?ZB647<F;;'6#P@@=NNV<,+8-J"(/01P !"@$* &$;[7,HIH$688C7I3:5T
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MKD< !@ !\9 R#V  _OD ]W $3,  J.)K,ZB;5+)G!7$#/B 1/*"@:4.9#X$
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MA'H2N>F](_)C78  IR9Q?%9Q-J@0>]:^UK.\.$F2\)LAL5L/ ""(%/AM5@<
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M$'Q9C%H@F?@G2<N&Q3IH$*8KNA$!E FQIIYB *&<-KQ\S>1A8TRP T^9#P=
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M(LSY]96Y+QZA:A"U*.Z,67##OVZO#C]^R "_;^W++QZ9_ZKZ5'</1TT1WWX
MT0W!$?$ 8! R!;"P16GZVT\276G1.2=NH,\0XT_\Z3S[;,)KD?S4$7+M  %
MX$""!0T>1)A0X4*&#1T^A!A1XD2*%2U>Q)A1(\8C#0P2X'$#0#PP!"R".9 R
MB$8#[282(.$ @;V- ^,QJ)E3YTZ>/7W^!!I4Z% ''@TV,,HQY0$#&N\5&/JP
M ).H5:U>Q9I5ZU:N!CL>Y %!(XF46N*Q=-F5H#^<:MV^A1M7[ER=10_>\*$1
M05E^3J'"G4I7\&#"A0UG!9.4((0O&ID<T+*#9L8 9^'>/)Q9\V;.G1/:]6D@
M99>^&5O&#>Q9]6K6K;4.4;QS'_]D(),Q&O 7EZUKWKU]_W[H  Q!T2)]%CB
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M9C_'[XW[MY)//WY^$Z>Q-\%!ES__?0'F@7SIMX*?_@2XH"!TX0'LXXV%7#9
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M>J0<6@HI)E,3])#_ BE*@A?<X ='>,(57LE]T)>C?T+ P DI\84+<HN*0L#
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M)I E69JEN=B+!EC*6FD 'DB9!@ ")D 4/Q3*@F@RW=$;[;&76"$!L"0!$BB
M?2"!'W2"([B!+M ")XB@R)@0=MS'K> '4R&!&V"L/^$!WV+$K)R(M/N^KM$E
M=W& HM ";HP)"%#%=F3'9/S)?#R ?4" .<+ R&"BAA"F5T2(4LHA70J"PG2
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M>D2(_^S$J(>D")L\" +@W9,A)8J !ZP<B% [$@-%@,*#B)Q4B/@H#3)2WH0
M3(7XLB;PPH@HRX8PT#SK7HB(!^$M")CXD $,WJ<R" -P3O2MB(Q:B'U0$@&!
ME>OMW>)5B/!]4O-="*KMP[,L3E-QSM8 D(;(CJ9(/>:C""=@WX)P+H'00A]
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M!]A-'M!FAICK5YD7\[MKO@D)@9C-6J'( &P-E.9F+3@B;&L D[J'W+"'F0:
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%BP@( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Dec. 19, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001000275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">ROYAL BANK OF CANADA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-275898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Dec. 19, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 2,564,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>11</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp238987_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp238987_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp238987_exfilingfees.htm">dp238987_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="9">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp238987_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp238987_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 11,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 9,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238987_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238987_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:NrrtvMaxAggtOfferingPric",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238987_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:NrrtvMaxAggtOfferingPric",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp238987_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950103-25-016365-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-016365-xbrl.zip
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M#=4HK1A1.;'7#,%WS@TG!^V<JP5]8>?--JU'*L46YED:';*1PP4G"#39-A;
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:+FAT;5!+!08      0 ! $<    ^!@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>dp238987_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001000275</identifier>
        </entity>
        <period>
            <startDate>2025-12-19</startDate>
            <endDate>2025-12-19</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001000275</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="fee_004">333-275898</ffd:RegnFileNb>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_005">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_006">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_007">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_008">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_009">ROYAL BANK OF CANADA</dei:EntityRegistrantName>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-40"
      unitRef="USD">2564000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-41">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
